Form 4: Hims & Hers Health CFO Oluyemi Okupe Executes Stock Option Exercise and Sales Under 10b5-1 Plan

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 2, 2025, according to a Form 4 filing with the SEC.

Summary

• On January 2, 2025, Oluyemi Okupe, the CFO of Hims & Hers Health, Inc. (HIMS), executed stock option exercises and sales of Class A Common Stock.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
• Okupe exercised options to acquire 6,437 shares at a price of $5.01 per share.
• He then sold 9,193 shares at a weighted average price of $24.6732, 1,391 shares at $24.7115, and 997 shares at $24.6632.
• Following these transactions, Okupe directly owns 123,221 shares of Class A Common Stock and 432,611 derivative securities (stock options).

Sentiment

Score: 5

Explanation: This is a routine Form 4 filing, indicating standard insider trading activity under a pre-arranged plan. It doesn't inherently suggest positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Monitoring insider transactions is a standard practice in financial analysis.
• Comparing Okupe's transactions to those of CFOs at comparable companies (e.g., Teladoc Health, GoodRx) could provide context.
• Analyzing the timing and size of these transactions relative to industry benchmarks for insider trading activity is important.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates